HCA Healthcare Inc
F:2BH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
HCA Healthcare Inc
F:2BH
|
US |
|
K
|
KLA Corp
XMUN:KLA
|
US |
|
Liberty Media Corp
NASDAQ:FWONK
|
US |
|
C
|
China Life Insurance Co Ltd
F:CHL
|
CN |
|
C
|
China Petroleum & Chemical Corp
LSE:SNP
|
CN |
|
G
|
Garmin Ltd
XHAM:GEY
|
CH |
|
Bank of Communications Co Ltd
F:C4C
|
CN |
|
O'Reilly Automotive Inc
NASDAQ:ORLY
|
US |
|
M
|
Mckesson Corp
DUS:MCK
|
US |
|
N
|
NTT Data Corp
F:NT5
|
JP |
|
ArcelorMittal SA
NYSE:MT
|
LU |
Wall St Price Targets
2BH Price Targets Summary
HCA Healthcare Inc
According to Wall Street analysts, the average 1-year price target for 2BH is 454.57 EUR with a low forecast of 326.69 EUR and a high forecast of 577.86 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2BH's stock price target?
Price Target
454.57
EUR
According to Wall Street analysts, the average 1-year price target for 2BH is 454.57 EUR with a low forecast of 326.69 EUR and a high forecast of 577.86 EUR.
What is the Revenue forecast for HCA Healthcare Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 8 years is 6%.
What is the Operating Income forecast for HCA Healthcare Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 8 years is 5%.
What is the Net Income forecast for HCA Healthcare Inc?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 8 years is 13%.
